Background. We performed a systematic review of foodborne botulism outbreaks to describe their clinical aspects and descriptive epidemiology in order to inform public health response strategies.
Foodborne botulism is a potentially fatal illness caused by consumption of food contaminated with neurotoxins produced by Clostridium botulinum and, rarely, by related species. Of the known types of botulinum toxin, types A, B, E, and F cause most human disease and deaths [1] . While outbreaks have been reported worldwide, characteristics of botulism outbreaks have never been systematically studied. A better understanding of the characteristics of outbreaks can assist with planning for future botulism events.
Current understanding of the epidemiology of a botulism outbreak relies on limited data from very few reports [2] [3] [4] . We performed a systematic review of worldwide foodborne botulism outbreaks published in the English literature. The purpose of the review was to describe the demographic characteristics; types of food sources and toxin types; clinical characteristics including adverse outcomes; time between exposure, symptom onset, and adverse outcomes; and outbreak duration. An improved understanding of the characteristics of botulism outbreaks can help inform clinicians and public health officials in their preparations for botulism events.
METHODS

Data Sources and Search Strategy
We searched Embase DIALOG, Embase OVID, Global Health OVID, Cochrane Library, CINAHL EBSCO, Scopus, and Medline OVID from database inception to May 2015 to identify indexed publications in the English literature using the following search terms: ["botulism, " "botulinum toxin, " or "Clostridium botulinum"]. The search strategy was developed with the assistance of an expert systematic review librarian (Centers for Disease Control and Prevention library). We also performed a hand-search of archived Morbidity and Mortality Weekly Reports articles and reviewed any additional articles identified by botulism subject matter experts and manuscript reviewers ( Figure 1 ).
Study Selection
We defined an outbreak as at least 2 cases of author-reported foodborne botulism with an epidemiologic link to the same food. Three reviewers (D. M. D., K. C. S., and S. F. D.) screened all titles and abstracts and conducted full text reviews for those that reported data on human cases of botulism and contained clinical or epidemiologic data on botulism outbreaks or did not contain information in the abstract to assess article content. Inclusion was limited to published reports in the English language. We excluded duplicate reports, reports related to nonfoodborne botulism outbreaks, and general reviews of foodborne outbreaks. Outbreaks deemed eligible must also have been based on articles that provided at least 1 outbreak time interval and case outcome. Data abstraction was conducted in duplicate and recorded in Excel and Access databases (Microsoft, Richmond, Washington).
Data Abstracted
For outbreaks in the review, we included author-reported total number of case-patients, irrespective of whether classic botulism symptoms or signs (cranial nerve palsy with or without descending weakness or paralysis) [5] were reported. When information was available, we identified cases with classic botulism symptoms who met criteria for laboratory-confirmed foodborne botulism (defined as patient's clinical specimens yielding C. botulinum or its toxin or if toxin was detected in the food consumed) [5] . Because case definitions varied among these author-reported outbreaks, we performed a subgroup analysis limited to laboratory-confirmed outbreaks that involved case-patients who had symptoms clinically compatible (ie, those consistent with cranial nerve palsy with or without descending weakness or paralysis) with botulism to assess the validity of our overall findings.
The number of cases per outbreak was dichotomized, using the 90th percentile as the cutoff to define outbreak size, as small (≤11 cases) or large (≥12 cases). For outbreaks that spanned multiple countries, the country from which the exposure originated was used for tabulation purposes. When a study reported a range of hours or days for a certain time interval (eg, "16-20 hours, " or "1-2 days"), the maximum value was used. "Time to symptom onset" referred to the onset of any symptom or sign following exposure. Point source outbreaks were defined as outbreaks caused by a single food consumed by all outbreak case-patients at a single time point. In contrast, intermittent common source outbreaks involved consumption of the implicated food by outbreak case-patients over a period of time. Where applicable, we classified suspected foods as "commercial products" or "noncommercial products. " Commercial products were defined as those prepared for sale or distribution by a business or restaurant. "Home-canned foods" were defined as noncommercial foods preserved at home using cans or jars. Noncanned, noncommercial foods prepared for individual or personal consumption in a noncommercial setting were grouped as "other noncommercial products. " Food sources were considered confirmed sources of an outbreak only when botulinum toxin was detected in the food [5] . Outbreaks were considered laboratory confirmed when at least 1 case-patient or the food source was laboratory confirmed. Toxin type was extracted from reports when available.
Data elements extracted included case demographics; clinical features; botulinum testing results; type of exposure; number of case-patients hospitalized, administered antitoxin, mechanically ventilated, or who died; clinical time intervals, including exposure to symptom onset, exposure to admission, and exposure to death; type of antitoxin administered; and dates of first and last exposure, symptom onset, and hospitalization. Data elements were extracted as available. Due to the limited amount of data reported by authors, we were unable to abstract information about comorbid conditions in a systematic manner. Data abstracted were independently reviewed by multiple reviewers. Discrepancies between reviewers were adjudicated through group discussion.
Quality Appraisal
Quality of the literature used was determined using a modified Newcastle-Ottawa scale adapted for this topic [6] and involved assigning a score from 0-9 (see Supplementary Materials 2).
Analytical Methods
Exposure source, implicated foods, and toxin type were compared across geographic locations, as were differences in exposure source and implicated food by outbreak size. Mortality was compared between outbreaks in which all case-patients received antitoxin matching the outbreak-associated toxin type vs outbreaks in which no case-patients received matching antitoxin. Bivariate analyses were restricted to outbreaks with complete data on the variables assessed.
The median time intervals for case-patients and mean proportions (hospitalizations, mechanical ventilations, deaths, and administrations of matching antitoxin) from each outbreak were abstracted or derived by reviewers from available data. For outcomes listed above, proportions are reported as means. As the data regarding time were skewed, time intervals are reported as medians of medians, with interquartile range of medians, similar to reported outbreak time intervals for other infectious diseases [7] . Primary analyses included all case-patients, regardless of clinical presentation or laboratory confirmation. Our subanalysis was restricted to laboratory-confirmed outbreaks that involved only case-patients whose clinical presentation was compatible with botulism. Comparisons between categorical variables were performed using χ 2 or Fisher exact tests. Differences between continuous variables were assessed using either Mann-Whitney U test or Kruskal-Wallis with Dunn's test. We built 3 logistic regression models to estimate the probability of a large outbreak as a function of exposure source, food type, or both. We combined homecanned and other noncommercial foods into a single category for comparison to commercial foods for our regression analysis. The reference groups used in the logistic models were noncommercial foods and point source exposures. All analyses were done using SAS 9.4 (SAS Institute Inc., Cary, North Carolina) or Stata 12 (College Park, Texas).
RESULTS
Search Results
Database and hand searches identified 16 822 publications of which 343 were selected for full text review ( Figure 1 ). A total of 206 publications met the inclusion criteria and described 197 outbreaks of foodborne botulism (Supplementary Materials 1).
General Outbreak Characteristics
The 197 eligible outbreaks included 1367 individual case-patients. The median number of case-patients per outbreak was 3, with a range of 2-97 ( Figure 2 ). Among outbreaks with date available, 183 were reported between 1920 and 2014. For the 114 outbreaks where the age of case-patients was reported, the median age per outbreak ranged from 6.5 to 78.5 years, with 74 (38%) outbreaks involving at least 1 pediatric patient (age <18 years) and 3 (1.5%) outbreaks reporting a case during pregnancy. Alternative diagnoses were considered and reported for 54 outbreaks. The most common alternative diagnoses reported in these outbreaks, for at least 1 case-patient, were viral infections (26%), myasthenia gravis (23%), and cerebrovascular events (19%). Eighty-six (44%) outbreaks were laboratory confirmed and involved only cases (n = 523) with clinically compatible botulism. A total of 13 asymptomatic case-patients were reported; 4 of these individuals were laboratory confirmed by detection of C. botulinum (n = 3) or toxin (n = 1) in stool. Seventy percent of outbreaks were due to a point source exposure (n = 138); the most common food (n = 83, 42%) was a homecanned product (Table 1 ). In 6% of outbreaks, the contaminated food was unknown. Toxin type A was reported in 34% of outbreaks, followed by type E (17%) and type B (16%; Table 1 ). Two outbreaks caused by toxin type F from Clostridium baratii were reported, 1 in France and 1 in Spain. In 64 (32%) outbreaks, the toxin type was not determined or not reported (Table 1) . Among the subgroup of 86 laboratory-confirmed outbreaks describing only clinically compatible case-patients, 74% were due to a point source exposure and 40% involved a home-canned food. Toxin type was known for 94% of these outbreaks, with type A the reported cause of 54% followed by type B (23%) and type E (21%; data not shown).
Outbreak Comparisons by Geographic Location
Outbreaks were reported from 27 countries, with 109 (55%) occurring in the United States and 29 (15%) in Canada; the remainder were in Europe (n = 25, 13%), Asia (n = 22, 11%), Africa (n = 6, 3%), Australia (n = 3, 2%), and 1 each in New Zealand, Argentina, and Greenland. Three outbreaks involved more than 1 country; all involved commercially distributed products. There was a significant difference (P < .001) in the type of food associated with outbreaks geographically ( Table 2 ). Similar trends were observed for the subset of laboratory-confirmed outbreaks with clinically compatible case-patients. Fifty (58%) occurred in the United States, 10 (12%) in Canada, 11 (13%) in Europe, 10 (12%) in Asia, and 5 (6%) in Africa. Of the 50 US outbreaks, 58% were associated with home-canned foods. In Europe, commercial products were most frequently implicated when compared to the United States (64% vs 15%, P < .001). Toxin type A was responsible for 58% of outbreaks in the United States, 45% in Europe, and 50% in Asia, while 50% of Canadian outbreaks were caused by toxin type E (data not shown). (Table 3) . Most of the small outbreaks originated from point source exposures. Among small outbreaks, 81% of point source exposures were associated with home-canned or other noncommercially processed foods; for large outbreaks, 50% of point source exposures were associated with home-canned or other noncommercially processed foods. In univariate analyses, intermittent common source exposure and commercial foods were both significantly associated with large outbreaks. In the multiple logistic regression model, only commercial food vehicles remained significantly associated with large outbreaks (odds ratio, 6.87; 95% confidence interval, 2.23-21.11; Table 3 ).
Outbreak Comparisons by Outbreak Size and
The median number of days for symptom onset between the first and last case-patient was <1 (range, <1-6 days) for point source outbreaks (Figure 3 ) and 5 (range, 1-62 days) for intermittent common source outbreaks (P < .0001). Similar findings were observed in our subset of laboratory-confirmed outbreaks with clinically compatible case-patients (data not shown). The incubation period was statistically significantly shorter in toxin type E outbreaks (median, 0.8 days; interquartile range [IQR], 0.4-1.0) compared to toxin type A outbreaks (median, 1.0 days; IQR, 1.0-2.0) and toxin type B outbreaks (median, 1.0 days; IQR, 1.0-2.0; P < .001; Table 4 ). There were no significant differences in terms of mean percentage of hospital admissions between toxin types A, B, and E outbreaks ( Table 4 ). The mean percentage of cases supported with mechanical ventilation was significantly higher in toxin type A outbreaks (43.6%; SD, 34.6%) compared to toxin type B outbreaks (24.5%; SD, 27.8%; P = .034), but no significant differences were noted for mean percentage of mechanically ventilated cases comparing either toxin type A or B outbreaks to toxin type E outbreaks. Compared to toxin type B outbreaks, toxin type E outbreaks had a shorter exposure to death interval (median, 1.7 days vs 6 days; P = .006), as well as a higher mean number of deaths per outbreak (2.4 vs 0.6; P = .014; Table 4 ). The interval from exposure to death and the mean percentage of deaths were not significantly different between toxin type A and toxin type E outbreaks. The absolute numbers compared were small in the subanalysis of laboratory-confirmed outbreaks with only clinically compatible case-patients and, in most instances, did not reach statistically significant differences. The only significant difference was a shorter incubation period for type E outbreaks (median, 0.8 days; IQR, 0.5-1 days) compared to type A outbreaks (median, 1 day; IQR, 1-2 days; P = .011; Table 4 ). Similar proportions of case-patients were admitted regardless of outbreak size. The mean percentage of cases mechanically ventilated was 34.9% (SD, 34.9) for small outbreaks compared to 20.1% (SD, 14.7) for large outbreaks. The mean percentage of deaths was 33.5% (SD, 35.5) for small outbreaks and 12.8% (SD: 19.2) for large outbreaks. The mean number of deaths was 1.2 (SD, 1.5) for small outbreaks and 4.1 (SD, 5.8) for large outbreaks. These findings failed to reach statistical significance at the P < .05 level (Table 5) . Similar trends were noted in the subanalysis (Table 5) .
A lower percentage of deaths was observed overall for outbreaks in which all case-patients received matching antitoxin compared to those outbreaks where no matching antitoxin was administered (7.8% vs 53.9%; P < .001; Table 6 ). This overall difference was due, in part, to significantly lower percentages of death in outbreaks due to toxin type A and toxin type E, in which all cases received matching antitoxin. Subanalysis of laboratory-confirmed outbreaks with only clinically compatible case-patients also revealed a lower percentage of deaths for toxin type A outbreaks in which all cases received matching antitoxin (Table 6 ). . c Both food type and exposure source: probability of larger outbreak = 1/1+e -α+β1(food type) +β2(exposure source) .
d Home-canned and other noncommercial foods were grouped together into a single noncommercial category.
Quality Appraisal Results
Outbreak reports were scored between 1 and 7, with a mean score of 5 (Supplementary Materials 2).
DISCUSSION
Our study highlights key characteristics of foodborne botulism outbreaks that can inform clinicians and public health officials in the development of preparedness and response plans. We found that point source outbreaks were the most common type of exposure source, although intermittent common sources still caused nearly a quarter of outbreaks. As expected, outbreak duration was significantly longer for intermittent common source outbreaks and longer still for those due to a commercial food. However, it is worth noting that for some point source outbreaks, the time from exposure to symptom onset or admission spanned several days. This is an important observation because when there is an outbreak with an unknown exposure, clinicians and public health officials should anticipate that cases may continue presenting for several days after the index case presents. Diverse food types were noted, suggesting that multiple food sources can serve as a conduit for botulism. This is consistent with an extensive report of 65 years of human botulism by Meyer and Eddie [8] . Better understanding of the epidemiology of botulism outbreaks can help tailor local prevention and public health response strategies. As previously reported [9] [10] , toxin type varied among geographic regions, likely reflecting different food preferences and availability. Outbreaks that involved toxin type E had the shortest median incubation period, and those that involved type A had the highest mean percentage of case-patients mechanically ventilated, consistent with previous reports [11] . Among all outbreaks, the lowest mean number of deaths was observed in toxin type B outbreaks, consistent with the usually milder clinical disease associated with this toxin type [11] . A significantly lower percentage of deaths was reported in outbreaks where all cases received appropriate antitoxin, which is similar to findings reported by others [12] [13] [14] . Recognizing the toxin types involved in regional outbreaks may be important for countries as they consider antitoxin sources and supplies.
This review is subject to certain limitations that may influence the generalizability of the findings. Most notably, this review is based on observational data. Our search strategy was restricted to only indexed English articles and therefore excluded outbreak reports that may have been published in other languages or were not indexed in referenced electronic databases. Further, because these outbreaks spanned nearly a century and occurred worldwide, substantial heterogeneity between outbreaks is to be expected, particularly with regard to differences in food preferences, methods of food preparation, the existence of food safety regulations, and access to the modern, intensive care often required for the clinical management of botulism. Data elements were incomplete in many reports, which limits the amount of data upon which to draw conclusions, such as whether medical comorbidities influenced outcomes. Additionally, the implicated toxin type was unknown in roughly a third of outbreaks; therefore, several of our analyses were restricted to only outbreaks where a specific toxin type had been identified.
Foodborne botulism outbreaks continue to be reported worldwide, and there is the potential for botulinum toxin to be used in an intentional bioterrorism event. The size and duration of outbreaks may vary depending on the type and sources of exposure, as well as whether an exposure is restricted to a focal geographic location or widely distributed. Clinicians and public health officials should consider these issues to proactively anticipate clinical resource management decisions, improve prevention strategies such as community outreach and messaging to reduce community-specific risk, and preparedness strategies such as antitoxin stockpiling and delivery. Ongoing surveillance and timely investigation of botulism outbreaks are critical to mitigate the public health impact of future botulism outbreaks.
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